Eli Lilly Sets Five-Day Deadline for 340B Hospitals to Submit Claims Data or Lose Discounts

Eli Lilly has issued a five-day deadline for hospitals participating in the federal 340B drug discount program to submit specific claims data, warning that it will terminate price breaks for facilities that fail to comply. The pharmaceutical company notified affected institutions that they must provide the requested information by the end of this period to maintain their eligibility for discounted pricing on the company’s products.

This mandate follows ongoing industry debates regarding the transparency and reporting requirements of the 340B program, which allows safety-net hospitals to purchase outpatient drugs at a reduced cost. By requiring the submission of claims data, the company seeks to verify how these discounts are applied and tracked within the hospital systems. Hospitals that do not meet the five-day window face the immediate loss of these price reductions, a move that could impact the operational budgets of facilities that rely on the program to provide care to underserved populations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI